[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618503":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":22,"locations":28,"responsibleParty":72,"collaborators":12,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":12,"enrollmentInfo":85,"targetDuration":12,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":12,"overallStatus":94,"whyStopped":12,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care Group","NO_INTERVENTION","Usual Care Group: Patients receive standard BP, lipids,glucose and physical activity management including guideline-directed medication and outpatient follow-up at 3, 6, 9, 12 months.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Digital Remote Management Group","EXPERIMENTAL","In addition to usual care, patients receive a 1-year intervention via a smartphone-based \"\"physician-machine collaboration\"\" platform：\n\n1. BP Management: Daily or weekly self-monitoring based on control status. System triggers alerts for BP \\>130\u002F80 mmHg and generates medication adjustment suggestions for physician approval.\n2. Lipid Management: Reminder for lab tests. OCR technology parses results. If LDL-C ≥2.6 mmol\u002FL, the system suggests regimen intensification for physician review.\n3. Blood Glucose Management: Reminder for lab tests. OCR technology parses results.If Fasting Blood Glucose (FBG) ≥6.1 mmol\u002FL for patients without diabetes and FBG ≥7.0 mmol\u002FL for patients with diabetes, the system suggests regimen intensification for physician review.\n4. Medication Management: Daily app-based reminders and clock-in tasks. Non-adherence triggers automated reminders and human follow-up.\n5. Health Education: Regular push of targeted articles\u002Fvideos on secondary prevention。",[18],"Other: Digital Remote Management Group",[20],{"type":6,"name":14,"description":16,"armGroupLabels":21,"otherNames":12},[14],[23],{"name":24,"role":25,"phone":26,"phoneExt":12,"email":27},"Liu He","CONTACT","13810720787","theliu@139.com",[29,40,48,56,64],{"facility":30,"status":12,"city":31,"state":12,"zip":12,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":12},"Beijing Anzhen Hospital, Capital Medical University, Beijing, China","Beijing","China","CN",{"type":35,"coordinates":36},"Point",[37,38],116.39723,39.9075,{"lat":38,"lon":37},{"facility":41,"status":12,"city":42,"state":12,"zip":12,"country":32,"countryCode":33,"cosmosGeoPoint":43,"geoPoint":47,"contacts":12},"The First Hospital of Jilin University, Changchun, China","Changchun",{"type":35,"coordinates":44},[45,46],125.32278,43.88,{"lat":46,"lon":45},{"facility":49,"status":12,"city":50,"state":12,"zip":12,"country":32,"countryCode":33,"cosmosGeoPoint":51,"geoPoint":55,"contacts":12},"The First Affiliated Hospital of Dalian Medical University, Dalian, China","Dalian",{"type":35,"coordinates":52},[53,54],121.60222,38.91222,{"lat":54,"lon":53},{"facility":57,"status":12,"city":58,"state":12,"zip":12,"country":32,"countryCode":33,"cosmosGeoPoint":59,"geoPoint":63,"contacts":12},"The Second Affiliated Hospital of Nanchang University, Nanchang, China","Nanchang",{"type":35,"coordinates":60},[61,62],115.85306,28.68396,{"lat":62,"lon":61},{"facility":65,"status":12,"city":66,"state":12,"zip":12,"country":32,"countryCode":33,"cosmosGeoPoint":67,"geoPoint":71,"contacts":12},"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China","Shanghai",{"type":35,"coordinates":68},[69,70],121.45806,31.22222,{"lat":70,"lon":69},{"type":73,"investigatorFullName":74,"investigatorTitle":75,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Chang sheng Ma","Director of cardiology department","100618503","digital-remote-management-for-care-and-continuous-optimization-versus-usual-care-to-reduce-risk-of-atherosclerotic-cardiovascular-diseases-digicare-ascvd-100618503",false,"NCT07332468","Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-ASCVD)","DigiCare-ASCVD","Inclusion Criteria:\n\n1. 10-year ASCVD risk ≥ 10%, calculated using the China-PAR risk prediction model\n2. Adultd aged ≥ 35 years\n3. Able to use a smartphone (or assisted by family) and agrees to remote management\n4. Signed informed consent\n\nExclusion Criteria:\n\n1. History of acute myocardial infarction, stroke, heart failure, malignant arrhythmia, or prior percutaneous coronary intervention or coronary artery bypass grafting surgery\n2. Moderate to severe hepatic dysfunction (Child-Pugh class B-C)\n3. CKD stages 4-5 (eGFR \\\u003C30 ml\u002Fmin\u002F1.73m²) or on dialysis\n4. Chronic obstructive pulmonary disease requiring ongoing home oxygen therapy or chronic oral steroid therapy as an outpatient\n5. Pregnant, planning to become pregnant within the next 12 months\n6. Life expectancy \\\u003C12 months (e.g., advanced malignancy, etc.);\n7. Cognitive impairment or communication disorder.","ALL","35 Years",{"count":86,"type":87},790,"ESTIMATED","INTERVENTIONAL",[90],"NA","The DigiCare-ASCVD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated whether digital remote management is superior to usual care in reducing risk of atherosclerotic cardiovascular diseases and improving blood pressure control, glycemic control, lipids control, medication compliance and lifestyle.",[93],"Atherosclerotic Cardiovascular Diseases","NOT_YET_RECRUITING","2025-12-31",{"date":97,"type":98},"2026-01-12","ACTUAL",{"date":100,"type":87},"2026-01",{"date":102,"type":87},"2027-04",{"name":5,"class":6},5]